Aevi Genomic Medicine Competitors and Similar CompaniesClear all
Aevi Genomic Medicine's competitors and similar companies include Nouscom, Orchard Therapeutics, MicrofluidX and CAMP4 Therapeutics.
 Aevi Genomic Medicine Aevi Genomic Medicine is dedicated to translating genetic discoveries into novel therapies. |  Nouscom Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
|  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  CAMP4 Therapeutics CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression. | ||
Founding Date | Founding Date 2000 | Founding Date 2015 | Founding Date 2015 | Founding Date 2018 | Founding Date 2016 |
Type | Type Subsidiary | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | |||||
Locations | Locations Wayne, US HQ | Locations Basel, CH HQ Roma, IT | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations HQ | Locations Cambridge, US HQ |
Employees | Employees 24 | Employees 633% increase | Employees 166 | Employees 405% decrease | Employees 66 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income ($41.9m) (FY, 2016) | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income N/A | Net income ($80.4m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 49m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 1.7m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 62.6m | Total funding raised $ 310.7m | Total funding raised $ 1.7m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Nouscom
HQ
Basel, CH
Employees
63↑ 3% increase
Nouscom is a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.
View companyOrchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View company
MicrofluidX
HQ
Employees
40↓ 5% decrease
MicrofluidX is a company that develops cell bioprocessing technology.
View companyCAMP4 Therapeutics
HQ
Cambridge, US
Employees
66
CAMP4 Therapeutics is a biotechnology company that develops antisense oligonucleotide therapeutics targeting gene expression.
View company